Advertisement

Q&A

expert Q&A
Nader shaikh
expert Q&A
Short-Course vs Standard-Course Treatment for UTIs In Pediatric Patients
12/01/2023

Nader Shaik, MD, MPH

Nader Shaik, MD, MPH
In this Q and A, Nader Shaik, MD, MPH, discusses the results of his team's recent study examining treatment failure rates of short-course vs standard-course antimicrobial therapy for the treatment of...
12/01/2023
Expert Q&A
Robin Gal
Expert Q&A
Using a Telehealth Model in the Management of Patients With Diabetes
11/30/2023

Robin Gal, MSPH, CCRA • Grazia Aleppo, MD, FACE, FACP •  Teresa McArthur, MS, RD, CDCES

Robin Gal, MSPH, CCRA • Grazia Aleppo, MD, FACE, FACP •  Teresa McArthur, MS, RD, CDCES...
In this Q and A, Robin Gal, MSPH, CCRA, Grazia Aleppo, MD, FACE, FACP, and Teresa McArther, MS, RD, CDES answer questions about their study that investigated the use of a virtual clinic to support...
11/30/2023
Expert Q&A
Stephen Biehl, RRT, RPFT
Expert Q&A
Race, Ethnicity in Pulmonary Function Test Interpretation
11/09/2023

Stephen Biehl, RRT, RPFT

Stephen Biehl, RRT, RPFT
In this Q and A, Stephen Biehl, RRT, RPFT, answers questions about the guidelines from the American Thoracic Society on the use of race-specific equations in the interpretation of pulmonary function tests,...
11/09/2023
Expert Q&A
Elmar Joura, MD
Expert Q&A
Long-Term Follow-Up Data on Sustained Immunogenicity, Safety for 9-Valent Human Papillomavirus Vaccine
11/08/2023

Elmar A. Joura, MD

Elmar A. Joura, MD
In this interview, Elmar Joura, MD, answers questions about the long-term follow-up data on sustained immunogenicity and safety for the 9-valent human papillomavirus (HPV) vaccine, including indications,...
11/08/2023
expert Q&A
margaret lampe
expert Q&A
Achieving Perinatal HIV Elimination Goals
10/31/2023

Margaret A. Lampe, RN, MPH

Margaret A. Lampe, RN, MPH
In this expert Q&A, Margaret A. Lampe, RN, MsC, discusses the elimination of perinatal HIV transmission, elimination goals set out by the CDC, next steps for research, and more.
10/31/2023
Expert Q&A
Ian Bouligny
Expert Q&A
Can Venetoclax-Based Strategies Be Used in Treating Patients With Secondary-Type AML Mutations?
10/30/2023

Ian Bouligny, MD

Ian Bouligny, MD
In this interview, Ian Bouligny, MD, answers questions about his team’s research that sought to determine the use of venetoclax-based strategies in patients with newly diagnosed secondary-type mutations of...
10/30/2023
Conference Coverage
Yuriko Fukuta, MD, PhD
Conference Coverage
Are Cytokines Such As IL-6 Associated With Post-COVID Conditions?
10/27/2023

Yuriko Fukuta, MD, PhD

Yuriko Fukuta, MD, PhD
Yuriko Fukuta, MD, PhD, discusses her research team's study, which evaluated the risk factors associated with post-COVID conditions. She presented her findings at IDWeek 2023 in Boston, MA.
10/27/2023
Expert Q&A
jacob
Expert Q&A
Increased Risk of Post-Discharge CVD Events Among Survivors of Sepsis
10/23/2023
In this interview, Jacob C. Jentzer, MD, Assistant Professor of Medicine in the Department of Cardiovascular Medicine at the Mayo Clinic in Rochester, Minnesota discusses the implications of his study and...
10/23/2023
Expert Q&A
Deya Jourdy
Expert Q&A
Chronic Sinusitis With Nasal Polyps
10/19/2023
In this interview, Deya N. Jourdy, MD, talks about the clinical features, prevalence, diagnosis, and treatment for nasal polyps, including what surgical options are available for patients.
10/19/2023
Expert Q&A
Will Herrington, MA, MBBS, MD
Expert Q&A
Effects of Empagliflozin in Patients With Chronic Kidney Disease
10/14/2023
In this Q and A, Chief Investigator of the EMPA-KIDNEY trial, William Herrington, MA, MBBS, MD, answers questions about the results of the trial, including the effects of the SGLT2 inhibitor, empagliflozin,...
10/14/2023